Adaptive Stress Response: The Hot Yoga Study
Molecular Networks Involved in the Adaptive Stress Response: The Hot Yoga Study
1 other identifier
interventional
20
1 country
1
Brief Summary
This is a small intervention study which is aimed at characterizing what is known as the adaptive stress response (also know as "hormesis") in women aged 30-45 years. Participants will perform Bikram Yoga in a room heated to 104°F (40°C) which is often referred to as "Hot Yoga". The hypothesis of this study is that a protective and health-promoting adaptive stress response can be induced in living humans by performing exercise in a hot environment. The primary question is:How does the body physiologically adapt to performing moderately vigorous exercise in a hot environment?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 24, 2024
CompletedFirst Posted
Study publicly available on registry
May 2, 2024
CompletedMay 2, 2024
April 1, 2024
3 months
April 24, 2024
April 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Inflammatory biomarkers
cytokines and hsCRP
Assessed at baseline, Intervention week1, intervention midpoint (3 weeks), end of intervention (Week 6). end of study (Week 12; after washout)
Blood Lipids
Lipid panel (milligrams per deciliter, mg/dL)
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
Hemoglobin A1C
Comprehensive Metabolic Panel (millimole per mole, mmol/mol)
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
Fasting glucose/insulin
Comprehensive Metabolic Panel (milligrams per deciliter, mg/dL)
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
Immune cell phenotypes
Percent Immune phenotypes
Measured at the Start of Intervention (Week1), intervention midpoint (Week 3), end of intervention (Week 6), and end of study (Week 12; after washout)
Secondary Outcomes (6)
Positive and Negative Affect Schedule (PANAS) (Measures Positive and Negative Mood)
Assessed at Baseline, Midpoint of Intervention (Week 3), End of Intervention (Week 6) and End of Study (Week 12)
PROMIS (Patient Reported Outcomes Measurement Information System) - Global Health Scale (Measures well-being)
Assessed at Baseline, Midpoint of Intervention (Week 3), End of Intervention (Week 6) and End of Study (Week 12)
Warwick-Edinburgh Mental Well-being Scale (WEMWBS) (Measures well-being)
Assessed at Baseline, Midpoint of Intervention (Week 3), End of Intervention (Week 6) and End of Study (Week 12)
Patient Health Questionnaire (PHQ-9) (Measures depression)
Assessed at Baseline, Midpoint of Intervention (Week 3), End of Intervention (Week 6) and End of Study (Week 12)
Generalized Anxiety Disorder (GAD-7)
Assessed at Baseline, Midpoint of Intervention (Week 3), End of Intervention (Week 6) and End of Study (Week 12)
- +1 more secondary outcomes
Other Outcomes (5)
Changes in body wieght
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
Changes Body Mass Index (BMI) in kg/m^2
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
Changes in waist-to-hip ratio (WHR)
Measured at Baseline, end of intervention (Week 6), and end of study (Week 12; after washout)
- +2 more other outcomes
Study Arms (2)
Hot Yoga Intervention
EXPERIMENTALBikram Hot Yoga intervention: Participants perform a minimum of 60-minutes of Hot Yoga (Bikram Sequence), 3x per week in a heated room (40 degrees C) for 6-weeks
Hot Yoga Washout
OTHERHot Yoga Washout: Participants complete a 6-week "Washout" period during which the participants performed no Hot Yoga.
Interventions
Active participants engage in a yoga intervention which entails participating in a minimum of 60-minutes of hot yoga (Bikram sequence), 3x per week in a heated room at 40 degrees C. The intervention will be 6-weeks of active intervention when they are participating in yoga, followed by an 6-week "washout" period where they will be asked to not practice yoga. Participants will be asked to give blood at 9 timepoints throughout the 12-week study, including baseline, week one, midpoint, end of Hot Yoga Intervention (Week 6) and after Washout (Week 12)
The "Washout" period consists of 6-weeks occurring immediately after the Hot Yoga Intervention during which the participants do not perform any hot yoga.
Eligibility Criteria
You may qualify if:
- Healthy, non-menopausal women between the aged 30 to 45 years (≥30 years and ≤45 years)
- Not pregnant/not planning to get pregnant during the study duration
- Have not previously participated in hot yoga in the last 12-months
- Able to give informed consent and be willing to participate for the entirety of the study
You may not qualify if:
- Agree to allow samples to be stored for future use
- Pass the preliminary health screening
- Answer no for every question on the Physical Activity Readiness Questionnaire (PAR-Q ) during preliminary screening
- fasting Triglycerides greater than 150 milligrams/deciliter
- Blood pressure greater than 130/90
- Body Mass Index equal to or greater than 30 or less than 19
- Fasting glucose greater than 125 milligrams/deciliter.
- Having a pacemaker or a defibrillator 10) Taking any of the following drugs:
- Taking greater than 100 mg aspirin/day
- Taking non-steroidal anti-inflammatory drugs or oral corticosteroids
- Taking monteleukast-type of allergy medications
- Use of statins, niacin or fibrates or other lipid lowering medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tucson Yoga Sol
Tucson, Arizona, 85704, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Floyd Chilton, Ph.D.
University of Arizona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Nutritional Sciences Director, Precision Nutrition & Wellness Initiative Associate Director,The BIO5 Institute
Study Record Dates
First Submitted
April 24, 2024
First Posted
May 2, 2024
Study Start
February 11, 2023
Primary Completion
May 13, 2023
Study Completion
May 15, 2023
Last Updated
May 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share